ARCHIVES

DCT Board Ok’s concept For In Vivo Combination Studies

This article is from The Cancer Letter archive.

Vol. 16 No. 45 | November 23, 1990

Download PDF Visit The Full Archive

Related Articles

Interactive R01 Scores Vary widely, Result Of separate Review

June 11, 1993

In Brief NCI-FDA Relations Tops, DeVita Says; Upon Talks to Candidates For Prospective Division

November 24, 1978

DRG Executives Names By DeVita as Director Of DEA; Other Sections Reportedly Made, Not Yet Approved

July 31, 1981

Doxil/Caelyx Survival 3 Weeks Longer Than Topotecan

November 28, 2003

In Brief: Judge Declines To Block NCI Contract Award

February 24, 1995

ACCC Workshop Set for Sept; Planning Grant Okd

June 6, 1975